<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neuroprotective effect of an alpha-amino-3-hydroxy-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-isoxazolepropionate (AMPA) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> YM90K [6-(<z:chebi fb="0" ids="50053">1H-imidazol-1-yl</z:chebi>)-7-<z:chebi fb="13" ids="29785">nitro</z:chebi>-2,3(1H,4H)-quinoxalinedione monohydrochloride] has been examined in a rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="1" pm="."><plain>Intravenous infusion of YM90K (2.5-20mgkg(-l)h(-l) for 4h) starting immediately after occlusion of the middle cerebral artery significantly reduced the cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume 24h after occlusion compared with the control group </plain></SENT>
<SENT sid="2" pm="."><plain>The protection at the highest dose was 39% (P &lt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>Similar protective effects were observed when YM90K (20mgkg(-1)h(-1) for 4h) was delayed up to 2h after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (45% reduction, P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>CNS1102 [N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-<z:chebi fb="0" ids="16628">methylguanidine</z:chebi> <z:chebi fb="16" ids="36807">hydrochloride</z:chebi>], a non-competitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, also reduced the cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume when 1.13mgkg(-1) was administered by intravenous bolus injection immediately after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, followed by intravenous infusion at 0.785mgkg(-l)h(-1) for 4h (35% reduction, P&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>This neuroprotective effect was not observed when administration was delayed lh after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that AMPA receptors might play a more important role than <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors in the late development of neuronal cell damage after focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> and that AMPA receptor blockade would be one beneficial strategy in treating <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>